NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

Clinical Neuroradiology, published by SPRINGER HEIDELBERG, is a leading journal in the fields of neurology and radiology, focusing on the intersection of clinical practice and cutting-edge imaging technologies. With an impressive impact factor and categorized within Q2 in Neurology (clinical) and Q1 in Radiology, Nuclear Medicine and Imaging, this journal is positioned at the forefront of scientific discourse, facilitating high-quality research dissemination from its origins in 2000 through to 2024. Situated in Germany, Clinical Neuroradiology provides a platform for researchers, professionals, and students to explore the latest advancements and insights in neuroimaging, ensuring that its readership remains at the vanguard of clinical practice. While it does not offer open access, the journal remains committed to fostering a vibrant academic community dedicated to enhancing patient care through innovative neuroradiological techniques and findings.

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.

JOURNAL OF NEURORADIOLOGY is a leading peer-reviewed journal dedicated to advancing the field of neuroradiology. Published by MASSON EDITEUR, and based in France, this journal serves as a vital resource for professionals and researchers focusing on clinical neurology and various imaging technologies. With an impressive impact factor reflective of its robust contribution to the literature—ranking in the Q2 quartile across categories such as Neurology (clinical), Radiological and Ultrasound Technology, and Radiology, Nuclear Medicine and Imaging—the journal is positioned prominently within its field. Researchers can access the journal through subscription options, providing valuable insights into the latest developments, techniques, and empirical studies that shape neuroradiological practices. With its inception dating back to 1974 and coverage extending to current advancements, JOURNAL OF NEURORADIOLOGY is crucial for fostering knowledge and innovation, making it indispensable for both seasoned experts and emerging scholars alike.

EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.

Journal of Stroke & Cerebrovascular Diseases, published by ELSEVIER, is a leading international peer-reviewed journal dedicated to advancing the research and understanding of stroke and cerebrovascular disorders. With an impressive impact factor reflective of its rigorous academic standards, this journal is indexed in the highest echelons of medical disciplines, boasting a Q1 classification in Rehabilitation and prominent rankings in related fields. Established in 1991 and converging its focus toward 2024, it serves as a vital resource for researchers and clinicians interested in the complexities and treatment of cerebrovascular conditions. The journal's broad scope spans essential categories such as cardiology, neurology, and surgery, making significant contributions that enhance clinical practices and patient outcomes. For researchers, professionals, and students alike, the Journal of Stroke & Cerebrovascular Diseases is not just a publication but a critical platform for sharing innovative findings and fostering impactful discussions within the medical community.

INTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.

Angiologia, published by ARAN EDICIONES, S A, serves as a vital platform for the dissemination of research and advancements in the fields of cardiology and cardiovascular medicine. Established in 1949, this Spanish journal has made significant contributions to understanding vascular health, although it currently holds a Q4 status in Scopus rankings, indicating a critical opportunity for emerging researchers to contribute to this evolving field. Spanning from 1949 to 1993 and resuming from 1996 to 2024, the journal reflects a rich history of academic discourse. With its ISSN 0003-3170 and E-ISSN 1695-2987, Angiologia is committed to enhancing the visibility of cardiovascular research, providing access to a diverse range of articles that cater to the needs of healthcare professionals, academics, and students aiming to deepen their understanding of angiological health. While the journal currently does not offer open access options, it remains significant in guiding future research and fostering innovations within the cardiology landscape.